文献速递免疫规划传染病防控与疫情报告职业卫生

马里巴马科接种与未接种新冠疫苗卫生工作者抗SARS-CoV-2抗体动力学及血清阳性率(2021年11月至2023年2月)

Kinetics and seroprevalence of anti-SARS-CoV-2 antibodies in vaccinated and unvaccinated health workers in Bamako, Mali, November 2021-February 2023.
PubMed 文献 · Vaccine · 2025-09-01

该前瞻性研究在巴马科对685名接种和413名未接种新冠疫苗的卫生工作者随访15个月,发现两组抗刺突蛋白和抗核蛋白抗体在前3个月呈上升趋势,之后维持较高且相对稳定水平,并与有症状及无症状COVID-19感染率呈负相关。

要点

  • 接种组685人与未接种组413人随访15个月,抗刺突蛋白抗体>98%、抗核蛋白抗体>91%维持较高且相对稳定。
  • 男性抗体应答较低,尤其抗核蛋白抗体低于女性(p<0.05)。
  • 接种病毒灭活疫苗可提高抗核蛋白抗体,但接种两剂及以上疫苗后抗体水平未见升高。

核心结论

  • 接种和未接种疫苗的卫生工作者抗刺突蛋白和抗核蛋白抗体均呈进行性升高,并与COVID-19感染率降低相关。
  • 研究结果强调自然免疫和疫苗诱导免疫的重要性,以及需评估15个月研究期之后的抗体水平和长期保护。

研究设计与样本

  • 前瞻性研究,纳入马里巴马科685名接种疫苗和413名未接种疫苗的卫生工作者(共1098人),随访15个月,前6个月每3个月随访一次,15个月时进行最终访视。
  • 采用ELISA检测抗刺突蛋白和抗核蛋白抗体,使用非参数检验和逻辑回归分析比较抗体水平并探究相关因素。

主要发现

  • 接种组和未接种组抗SARS-CoV-2抗体在前3个月均呈上升趋势,3个月后抗刺突蛋白抗体>98%、抗核蛋白抗体>91%维持较高且相对稳定,并与有症状及无症状COVID-19感染率呈负相关。
  • 男性抗体应答较低,尤其抗核蛋白抗体低于女性(p<0.05);有合并症的卫生工作者抗体应答较高;活动性SARS-CoV-2感染者抗体水平降低。
  • 接种组抗刺突蛋白抗体呈较高趋势;接种病毒灭活疫苗可提高抗核蛋白抗体;接种两剂及以上疫苗后抗体水平未见升高,与使用同种或不同种疫苗无关。
  • 入组时不同血型参与者的抗核蛋白抗体存在显著差异。

局限性

  • 研究结论指出需评估15个月研究期之后的抗体水平和长期保护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This prospective study aimed to evaluate the dynamics and seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of vaccinated and unvaccinated health workers (HWs) in Bamako, Mali. The study also measured antibody responses as a function of SARS-CoV-2 infections, socio-demography, vaccination status and associated comorbidities. METHOD: 685 vaccinated and 413 unvaccinated HWs (total = 1098) were monitored over a 15-month periods with follow-up visits every 3 months for the first 6 months and a final visit after 15 months. Anti-spike and anti-nucleoprotein antibodies were assessed using ELISA. Non-parametric tests and logistic regression analyses were performed to compare antibody levels and to investigate associated factors. RESULTS: Overall, anti-SARS-CoV-2 antibodies tended to increase over the first 3 months in both vaccinated and unvaccinated groups. Spike (>98 %) and nucleoprotein (>91 %) antibodies remained high and relatively stable after 3 months and correlated inversely with the rate attack of symptomatic and asymptomatic COVID-19. Males demonstrated lower antibody responses, particularly for nucleoprotein (p < 0.05) compared to females. HWs with comorbidities demonstrated higher antibody responses. Participants with active SARS-CoV-2 infections exhibited decreased antibody levels. Vaccinated participants exhibited a trend toward higher spike antibodies. Virus-inactivated type vaccination increased nucleoprotein antibodies. Furthermore, there was no increase of antibody levels after receiving, two or more vaccine doses, independently of whether the same or a different type of used vaccines. Nucleoprotein antibodies varied significantly at inclusion among participants across blood groups. CONCLUSION: This study identified a progressive increase in anti-spike and anti-nucleoprotein antibodies in both vaccinated and unvaccinated HWs, correlating with reduced COVID-19 infection rates. These findings highlight the significance of both natural and vaccine-induced immunity and the need to assess antibody levels and long-term protection beyond the 15-month study period.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Balam S, Kane F, Traore B, et al. Kinetics and seroprevalence of anti-SARS-CoV-2 antibodies in vaccinated and unvaccinated health workers in Bamako, Mali, November 2021-February 2023. Vaccine. 2025. PMID: 40897596. doi:10.1016/j.vaccine.2025.127680

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。